Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Physical activity, height, and smoking affect prostate cancer risk.

A group has developed therapies that show promise for treating cancer and various other conditions.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.

Reflexology massage helps hair regrowth in women after chemotherapy.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Targeted cancer therapies often cause serious skin problems that need careful management.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.